Enara Alakano Grant 2025 - PRESARC

GEIS is pleased to announce the winner of the 1st Grant Enarak Behar Zaitu for the research on sarcoma was winned by Dr. Claudia Valverde, Medical Oncologist at University Hospital Vall d'Hebron (Barcelona, Spain) for the project PRESARC (PREdiction on retroperitoneal SARComas), which proposes the development of predictive models based on radiomics and artificial intelligence in order to improve the differential diagnosis and surgical planning of retroperitoneal sarcomas. This tool could contribute to more accurate decision-making, reduce unplanned surgeries, and optimize clinical outcomes for patients. The project will be a collaboration between multidisciplinary teams from the Sant Pau, Gregorio Marañón, Virgen del Rocío, and Vall d'Hebrón hospitals. 

The grant Enarak Behar Zaitu is possible thanks to the commitment of the patient Enara and her family, as well as to all people and groups which collaborated to make this initiative possible. Her support is a opportunity to advance in the research on sarcoma and in improvement on patient care.

From @geis_sarcomas we contratulate the winner and are most grateful to Enara for her generosity, which allows to develop projects with scientific and clinical impact.

#sarcoma #research #sarcomaawareness #sarcomagrant #InvestigaciónMédica #sarcomaresearch

GEIS XXIII International Symposium 2025

The GEIS 2025 International Sarcoma Symposium, held in Zaragoza (Spain), concluded after an intense day dedicated to scientific exchange, updating knowledge, and strengthening collaboration between professionals, researchers, and patient associations.

During the meeting, national and international experts shared the latest advances in the diagnosis and treatment of sarcomas, especially chondrosarcoma, addressing key topics such as biomarkers, sarcoma subtypes, bone tumors, and the most recent clinical challenges.

The symposium also included a section dedicated to the voices of patients and their associations, who provided essential insight into the daily challenges of diagnosis, access to treatment, and quality of life.

From GEIS (Grupo Español de Investigación en Sarcomas) we would like to express our gratitude to all the speakers for the quality of their presentations, to the attendees for their active participation, and to the patient associations for their commitment and ongoing support.

A special acknowledgment to our sponsors -- Deciphera, Bayer, Cogent Biosciences, PharmaMar y SpringWorks Therapeutics -- for their support, which makes possible this meeting.

GEIS continues working toward a common goal: to advance research and improve treatments for sarcoma patients, building a future together with greater knowledge and hope.

#sarcoma #research #sarcomaawareness #sarcomaresearch #sarcomaeducationalmeeting #sarcomapatients

ELENA HUELVA GRANT -INTEREWING

Last March, 7th we witnessed the generosity of the human heart.

Elena Huelva's family @emihupa, @emipalomo4, @huelva_manuel, thanks to the collaboration of the team of @juegaterapiaorg, made Elena's dreams real. An emotive act, with the music of @valeria.c. We are sure Elena would have loved it.

From @geis_sarcomas and SEHOP, we are grateful for the support to the research that, through the grant #becaelenahuelvajuegaterapia, make it possible ofr Spain to participate in the European trial InterEwing-1 to improve the prognostic of recently diagnosed patients.

Thank you for delivering hope to many homes and for making them realise they are not alone. #teruelexisteylossarcomastambien #sarcoma #research #sarcomaawareness

2Y4A9996 min

2Y4A0156 min

2Y4A0220 min

2Y4A9946 min

Grupo Español de Investigación en Sarcomas (GEIS) and Fundación Mari Paz Jiménez Casado (FMPJC), signed the 10th Annual Collaboration Agreement 2023 to support research on Sarcomas

Madrid, February 2023. One more year the Fundación Mari Paz Jiménez Casado (MPJC) and the Grupo Español de Investigación en Sarcomas (GEIS) have signed a collaboration agreement to support education and research on Sarcomas.
Both parties have renewed the agreement as a result of the success obtained in joint activities developed since 2013.
In 2023, the collaboration will be as follows:

Academic Educational Area course 2022-2023:

2 Grants of the FMPJC in the amount of € 1,000 for the V Máster Universitario Tumores Musculoesqueléticos by GEIS / Universidad Europea (UE), and collaborate with at least 2 grants in the amount of €1,000 for the course 2023/24.
Prize of the FMPJC in the amount of € 250 to the student who obtains the best mark in the V Máster on Sarcomas and the best mark in the XV Curso Avanzado de Sarcomas organised by GEIS, and which will be held in October 2023.
GEIS suppport to hold the VI Curso de Enfermería Oncológica en Sarcomas.

Clinical Educational Area:
Call of the 10th Edition of the FMPJC Grant "Rotación Clínica sobre Sarcomas en centro de referencia Internacional" for a period of up to 6 months and in the amount of up to € 15,000 (gross). -

Call of the 8th Edition of the FMPJC Grant "Rotación de Enfermería Oncológica en Sarcomas" in a reference center for up to 2 months and in the total amount of up to € 3,500.

Call of the 6th Grant of the FMPJC of support for International Observer in the amount of up to € 2,000.

Research Area:

7th Triennial Grant of the FMPJC on Research on Sarcomas in the amount of € 75,000 gross (€ 25,000 per year).

The FMPJC will continue to partially support the grants of the 17th Edition of the "Becas José Mª Buesa" of GEIS in the amount of € 5,000.

XIV Congress SEHOP 2022

XIV Congreso Nacional de la Sociedad Española de Hematología y Oncología Pediátrica (SEHOP).

www.geyseco.es/sehop2022

Secretaría Técnica GEYSECO

This email address is being protected from spambots. You need JavaScript enabled to view it.